TABLE 3.

Effects on quality of life

QoL domain	AD			oPEP
	Baseline	4 weeks	p-value	Baseline	4 weeks	p-value
Subjects n	25			24
Respiratory symptoms	67 (44–79.5)	70 (50–79.5)	0.732	65 (46–77)	72 (48.8–80.3)	0.139
Physical functioning	60 (20–83.5)	67 (37–86.5)	0.393	53.5 (21.8–93)	60 (36.5–87)	0.412
Vitality	44 (27.5–66.8)	67 (44–67)	0.027	44 (1–100)	50 (33–67)	0.231
Role functioning	73 (53–87)	87 (56.5–93)	0.073	70 (41.8–87)	73 (48.5–80)	0.970
Emotional functioning	83 (54–100)	83 (62.5–100)	0.611	79 (60.3–92)	79 (67–98)	0.690
Social functioning	50 (21–67)	58 (37.5–76.5)	0.042	n=23 58 (42–83)	n=23 58 (44–75)	0.919
Treatment burden	n=20 56 (33–78)	n=20 44 (33–64.3)	0.085	n=20 56 (35.8–75.3)	n=20 56 (33.3–67)	0.458
Health perceptions	42 (33–67)	58 (42–75)	0.177	33 (25–58)	42 (33–64.8)	0.048

Scores presented as median (interquartile range) unless otherwise stated. Domains of the quality of life questionnaire for bronchiectasis (QoL-B) [21] were scored on a scale of 0 (worst) to 100 (best) and compared between baseline and end-of-study visits. QoL: quality of life; AD: autogenic drainage; oPEP: oscillating positive expiratory pressure. Values in bold represent p<0.05.